Resapp just reported its second CE Mark for its smartphone App following there first success just a few weeks ago.
No delays, no second, third meetings. All done thru BSI.
We we have waited 5 years. All we got were please provide another costly study with 20 patients. We did this and provided 42 patients and still got rejected.
Millions of dollars spent on clinical studies, meetings etc etc. Poster presentations at medical conferences. Still no details on any meeting with BSI or COC. Almost 2 months passed since our latest revised submission. Not a word from BSI.
5 years of shareholder pain and suffering. Not to mention the patients.
OSL Price at posting:
6.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)